Timothy R Sterling
Overview
Explore the profile of Timothy R Sterling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
293
Citations
9389
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phillips P, Peloquin C, Sterling T, Kaur P, Diacon A, Gotuzzo E, et al.
Am J Respir Crit Care Med
. 2025 Mar;
PMID: 40080768
Background: Evaluation of optimal dosing has generally been inadequate during TB drug development. Fluoroquinolones are central to TB treatment. We aimed to determine the dose of levofloxacin needed to achieve...
2.
Mendelsohn S, Mulenga H, Tameris M, Moloantoa T, Malherbe S, Katona A, et al.
medRxiv
. 2025 Feb;
PMID: 39974049
Background: More than half of tuberculosis (TB) detected by community prevalence surveys is classified as asymptomatic. We evaluated yield of symptom and chest radiograph (CXR) screening of TB-exposed household contacts...
3.
Ingle S, Trickey A, Lankina A, McGinnis K, Justice A, Cavassini M, et al.
Alcohol Clin Exp Res (Hoboken)
. 2025 Jan;
49(2):407-417.
PMID: 39779221
Background: Alcohol use is measured in diverse ways across settings. Harmonization of measures is necessary to assess effects of alcohol use in multi-cohort collaborations, such as studies of people with...
4.
Ridolfi F, Amorim G, Haas D, Arriaga M, Staats C, Cordeiro-Santos M, et al.
Res Sq
. 2025 Jan;
PMID: 39764089
Background: Human genetic variants can affect TB and HIV drug metabolism, which may lead to toxicity or treatment failure. We evaluated associations between genetic variants of antiretroviral therapy (ART) and...
5.
Nogueira B, Rangel F, Andrade A, Daniel E, Figueiredo M, Staats C, et al.
J Infect Dis
. 2025 Jan;
PMID: 39763217
There are insufficient predictors of progression to tuberculosis among contacts. A case-control study within RePORT-Brazil matched 20 QuantiFERON-positive progressors and 40 non-progressors by sex, age, and exposure duration. Twenty-nine cytokines...
6.
Villalva-Serra K, Barreto-Duarte B, Rodrigues M, Queiroz A, Martinez L, Croda J, et al.
Lancet Reg Health Am
. 2025 Jan;
41:100963.
PMID: 39759249
Background: Despite government efforts, tuberculosis (TB) remains a major public health threat in Brazil. In 2023, TB incidence was 39.8 cases per 100,000 population, far above the WHO's target of...
7.
Coburn S, Pimentel N, Leyden W, Kitahata M, Moore R, Althoff K, et al.
J Acquir Immune Defic Syndr
. 2024 Dec;
96(4):393-398.
PMID: 39720558
Background: The effect of initial antiretroviral therapy (ART) class on cancer risk in people with HIV (PWH) remains unclear. Setting: Cohort study of 36,322 PWH enrolled (1996-2014) in the North...
8.
Amorim G, Jaworski J, Yang J, Cordeiro-Santos M, Kritski A, Figueiredo M, et al.
Pharmacogenet Genomics
. 2024 Oct;
35(2):55-64.
PMID: 39470346
Background: Genetic polymorphisms have been associated with risk of antituberculosis treatment toxicity. We characterized associations with adverse events and treatment failure/recurrence among adults treated for tuberculosis in Brazil. Methods: Participants...
9.
Rebeiro P, Thome J, Gange S, Althoff K, Berry S, Horberg M, et al.
Health Aff Sch
. 2024 Oct;
2(10):qxae128.
PMID: 39445109
HIV care continuum outcome disparities by health insurance status have been noted among people with HIV (PWH). We therefore examined associations between state Medicaid expansion and HIV outcomes in the...
10.
Piekos J, Amorim G, Ridolfi F, Cordeiro-Santos M, Kritski A, Figueiredo M, et al.
medRxiv
. 2024 Sep;
PMID: 39252933
Tuberculosis (TB) treatment is highly effective, but response to therapy can vary by geography, race, and ethnicity. We assessed for differences in TB treatment response in a representative and heterogeneous...